Diagnostic imaging company RadNet, via DeepHealth, its wholly-owned subsidiary, has acquired AI ultrasound imaging company See-Mode Technologies. See-Mode’s AI-powered ultrasound detection, characterization and reporting application for thyroid and breast will be integrated into RadNet’s DeepHealth…
Continue Reading
The FDA launched Elsa, a generative AI tool designed to help employees, including scientific reviewers and investigators, work more efficiently. In a statement, the agency said the tool “modernizes agency functions and leverages AI capabilities…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ori Warshavsky, COO at PolyPid. With a platform that anchors drug delivery…
Continue Reading
Revolutionary AI Platform Announcement
The U.S. Food and Drug Administration has officially launched Elsa, a groundbreaking generative FDA AI technology designed to revolutionize how agency employees perform their daily tasks. This innovative platform represents a…
Breakthrough AI Technology Transforms Portable Brain Imaging
Hyperfine Inc., the pioneering company behind the world’s first FDA-cleared AI-powered portable MRI system, has achieved another significant milestone with FDA clearance of its groundbreaking Optive AI software….
News
RCM AI company Amperos Health announces $4.2 million in seed funding and the launch of Amanda, an AI tool designed to help providers automate denial management and collections.
The FDA launches Elsa, a generative AI…
Continue Reading
The U.S. Food and Drug Administration on Monday announced the launch of a new generative AI technology that agency leaders said will help its employees do their jobs more efficiently.WHY IT MATTERSThe tool, called…
Continue Reading
Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite.Viz.ai offers a care coordination platform featuring over 50…
Continue Reading
This project represents the first systematic assessment of the US Food and Drug Administration’s postmarket surveillance of legally marketed artificial intelligence and machine learning based medical devices. We focus on the Manufacturer and User…
Continue Reading
Portal Access, an oncology-focused medical device startup, closed a $7 million Series A financing round.The company said that more than 80% of the round was led by U.S. physician investors, including oncologists, interventional radiologists,…
Continue Reading
